Polymerase Capital - aVenture Asset Manager Research
Polymerase Capital
Operating Status: Operating
Polymerase Capital: A venture capital firm investing in life science enterprises.
Location
Seattle, WA, US
Founded
2021
Polymerase Capital is a venture capital firm specializing in life science investments. The firm focuses on early-stage companies, particularly those seeking Series A funding. While specific investment sizes are not disclosed, Polymerase Capital demonstrates a commitment to supporting innovative enterprises in the biotechnology and healthcare sectors.
One of Polymerase Capital's notable portfolio companies is Genascence, which has raised $10.5 million in funding. The firm's investment strategy appears to target companies with promising scientific advancements and potential for significant impact in the life sciences industry. Polymerase Capital likely provides strategic guidance and industry expertise to help its portfolio companies navigate the complex landscape of biotechnology and healthcare innovation.
Polymerase Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.